Related Experiment Video

Updated: Jun 18, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

Hyperkalemia in patients with heart failure: incidence, prevalence, and management

Akshay S Desai1

  • 1Advanced Heart Disease Section, PBB-A3-AB370, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. adesai@partners.org

Current Heart Failure Reports
|December 2, 2009
PubMed

Insights

Heart failure medications improve outcomes but can raise potassium levels, leading to dangerous hyperkalemia. Careful patient selection and monitoring are crucial for safe and effective treatment.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Multilevel neurohormonal inhibition is standard for heart failure (HF).
  • Key HF medications include ACE inhibitors, beta-blockers, ARBs, and aldosterone antagonists.
  • These therapies improve HF morbidity and mortality but risk hyperkalemia.

Purpose of the Study:

  • To review the mechanisms, incidence, predictors, and management of hyperkalemia in heart failure patients.
  • To emphasize the importance of patient selection and monitoring during HF pharmacotherapy.

Main Methods:

  • Literature review focusing on hyperkalemia in heart failure.
  • Analysis of factors contributing to impaired potassium excretion in HF patients.
  • Discussion of clinical strategies for managing hyperkalemia.

Main Results:

  • Hyperkalemia is a significant risk in HF patients, especially those with comorbidities like diabetes or chronic kidney disease.
  • Impaired renal function and advanced age increase hyperkalemia risk.
  • Optimal dosing and regular monitoring of potassium and creatinine are vital.

Conclusions:

  • Effective HF management requires balancing therapeutic benefits with hyperkalemia risks.
  • Careful patient selection and vigilant monitoring are essential for preventing and managing hyperkalemia.
  • This approach ensures safer and more effective heart failure treatment.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...